Top Wall Street Picks: Nvidia, Amazon, and More
- Major analysts have made high-profile calls on leading companies like Nvidia and Amazon, suggesting potential growth.
- Other notable mentions include Synchrony and Eli Lilly, showcasing a diverse range of sectors.
- These insights reflect Wall Street's expectations and could influence investor decisions.
Morgan Stanley has upgraded Third Harmonic to an overweight rating, encouraging investors to capitalize on recent dips in the biotech company's shares. The firm also initiated coverage of Vericel Corp with a buy rating and a price target of $57, signaling confidence in the company's growth potential. Additionally, Morgan Stanley upgraded General Dynamics, emphasizing the defensive nature of the defense sector, and raised Burlington's rating to buy while maintaining a price target of $10 for GDRX, which they believe has been oversold. Barclays has similarly upgraded Ingredion to overweight from equal weight, citing expected margin expansion following strong financial results and an increase in guidance. The new price target for Ingredion is set at $145, up from $122, reflecting optimism about the company's future performance in the food ingredients market. In other notable upgrades, Bank of America has added Uber and Chipotle to its US 1 list, highlighting a positive outlook for both companies. The firm also upgraded Synchrony and Bread Financial to buy, noting improving credit trends among card issuers. Furthermore, Bank of America reiterated its buy rating for Amazon, following news that TikTok and Pinterest will facilitate in-app shopping for the e-commerce giant. Lastly, Deutsche Bank initiated coverage of Inari Medical with a buy rating, indicating strong positioning in the medical device sector, while Jefferies upgraded Confluent to overweight, citing an attractive risk/reward scenario for the software company.